Individual Choice of Delivery Mode

October 16, 2018 updated by: University Women's Hospital Tübingen

Individual Choice of Delivery Mode - A Prospective Study Using Online Surveys

The primary aim of the study is to investigate personal attitudes regarding mode of delivery among both medical health care professionals and non-professionals. The investigators are also investigating whether providing detailed information that might influence one's decision regarding mode of delivery (such as education on pelvic floor disorders or advantages or disadvantages of epidural anaesthesia) will change participants´ opinion how to determine their preferred mode of delivery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The choice of delivery mode is an individual decision that is affected by personal opinions and feelings about what might be best for one's own body and child. Increasing awareness about the risks of vaginal delivery has led to an increasing rate of cesearean delivery on maternal request.

The primary aim of the study is to investigate personal attitudes regarding mode of delivery among both medical health care professionals and non-professionals. The investigators are also investigating whether providing detailed information that might influence one's decision regarding mode of delivery (such as education on pelvic floor disorders or advantages or disadvantages of epidural anaesthesia) will change participants´ opinion how to determine their preferred mode of delivery.

A secondary aim of the survey is to gather information about personal attitudes regarding:

  • epidural anaesthesia for pain relief during delivery
  • systems of risk stratification
  • postnatal recovery exercises The data will be acquired with an online questionnaire designed for this study. There will be two groups in this study. The first group ("medical professionals") consists of gynecologists with either subspecialization (urogynecology , fetal and maternal medicine, obstetrics, other) and other non-OB/GYN health care providers and medical staff, regardless whether they are nurses, medical assistants, physicians, physiotherapists, midwifes, administration staff. The group of "non-professionals" consists of women who are currently pregnant, and are not healthcare professionals.

Study Type

Observational

Enrollment (Actual)

2605

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tübingen, Germany, 72076
        • University Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

There will be two groups in this study. The first group ("medical professionals") consists of gynecologists with either subspecialization (urogynecology , fetal and maternal medicine, obstetrics, other) and other non-OB/GYN health care providers and medical staff, regardless whether they are nurses, medical assistants, physicians, physiotherapists, midwifes, administration staff. The group of "non-professionals" consists of women who are currently pregnant, and are not healthcare professionals.

Inclusion Criteria:

Participants in the "medical professionals" group can be from either gender, over age 18, currently working in the medical profession and have sufficient understanding of the German language in order to be able to fill out the questionnaire.

The "non-professionals" are pregnant females over age 18 with sufficient understanding of the German language in order to be able to fill out the questionnaire.

Description

Inclusion Criteria:

  • able to fill out a questionnaire

Exclusion Criteria:

  • minor people

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Staff of the University Clinic of Tuebingen
Online-based questionnaire
Participants receive a web-link to a questionnaire, which is active for 3 months
Participants of the 9th German Urogynecological Congress
Online-based questionnaire
Participants receive a web-link to a questionnaire, which is active for 3 months
All members of the German Society of Obsetrics and Gynecology
Online-based questionnaire
Participants receive a web-link to a questionnaire, which is active for 3 months
Pregnant women from Tübingen and Heidelberg
Online-based questionnaire
Participants receive a web-link to a questionnaire, which is active for 3 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delivery mode
Time Frame: 3 months
Choice of delivery mode
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2017

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

April 24, 2017

First Submitted That Met QC Criteria

April 24, 2017

First Posted (Actual)

April 27, 2017

Study Record Updates

Last Update Posted (Actual)

October 17, 2018

Last Update Submitted That Met QC Criteria

October 16, 2018

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • DECISION

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delivery Mode

Clinical Trials on Online-based questionnaire

3
Subscribe